Susquehanna International Group
HZNP

Susquehanna International Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Susquehanna International Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-347,967
Closed -$40.3M – 13788
2023
Q3 		$40.3M Buy
347,967
+11,972
+4% +$1.29M 0.01% 1157
2023
Q2 		$34.6M Sell
335,995
-18,559
-5% -$1.96M 0.01% 1244
2023
Q1 		$38.7M Sell
354,554
-346,811
-49% -$38.3M 0.01% 1119
2022
Q4 		$79.8M Buy
701,365
+263,486
+60% +$21.9M 0.02% 652
2022
Q3 		$27.1M Sell
437,879
-8,592
-2% -$600K 0.01% 1172
2022
Q2 		$35.6M Buy
446,471
+275,097
+161% +$26.1M 0.01% 1036
2022
Q1 		$18M Sell
171,374
-17,693
-9% -$1.72M ﹤0.01% 1838
2021
Q4 		$20.4M Sell
189,067
-4,969
-3% -$542K ﹤0.01% 1830
2021
Q3 		$21.3M Buy
194,036
+78,431
+68% +$8.14M ﹤0.01% 1913
2021
Q2 		$10.8M Sell
115,605
-297,796
-72% -$27.4M ﹤0.01% 2797
2021
Q1 		$38M Buy
413,401
+51,845
+14% +$4.38M 0.01% 1314
2020
Q4 		$26.4M Buy
361,556
+271,811
+303% +$20.2M ﹤0.01% 1457
2020
Q3 		$6.97M Buy
89,745
+75,218
+518% +$5.18M ﹤0.01% 2657
2020
Q2 		$807K Sell
14,527
-18,376
-56% -$786K ﹤0.01% 6382
2020
Q1 		$975K Buy
32,903
+12,711
+63% +$430K ﹤0.01% 5473
2019
Q4 		$731K Sell
20,192
-3,895
-16% -$119K ﹤0.01% 6171
2019
Q3 		$656K Sell
24,087
-131,417
-85% -$3.4M ﹤0.01% 6669
2019
Q2 		$3.74M Buy
+155,504
New +$3.94M ﹤0.01% 3120
2018
Q2 		– Sell
-99,787
Closed -$1.52M – 10856
2018
Q1 		$1.42M Sell
99,787
-332,171
-77% -$4.91M ﹤0.01% 4548
2017
Q4 		$6.31M Sell
431,958
-111,473
-21% -$1.57M ﹤0.01% 2280
2017
Q3 		$6.89M Sell
543,431
-382,465
-41% -$4.86M ﹤0.01% 2141
2017
Q2 		$11M Buy
925,896
+588,508
+174% +$7.32M ﹤0.01% 1624
2017
Q1 		$4.99M Sell
337,388
-433,824
-56% -$7.03M ﹤0.01% 2359
2016
Q4 		$12.5M Sell
771,212
-289,811
-27% -$5.26M 0.01% 1366
2016
Q3 		$19.2M Buy
1,061,023
+563,195
+113% +$11M 0.01% 1043
2016
Q2 		$8.2M Sell
497,828
-446,465
-47% -$7.22M ﹤0.01% 1626
2016
Q1 		$15.6M Buy
944,293
+939
+0.1% +$16.4K 0.01% 1167
2015
Q4 		$20.4M Sell
943,354
-124,190
-12% -$2.42M 0.01% 1125
2015
Q3 		$21.2M Buy
1,067,544
+177,766
+20% +$5.62M 0.01% 1157
2015
Q2 		$30.9M Buy
889,778
+311,667
+54% +$9.51M 0.01% 976
2015
Q1 		$15M Buy
578,111
+298,041
+106% +$5.46M 0.01% 1490
2014
Q4 		$3.61M Buy
280,070
+58,801
+27% +$736K ﹤0.01% 3408
2014
Q3 		$2.72M Buy
221,269
+118,399
+115% +$1.38M ﹤0.01% 4074
2014
Q2 		$1.63M Buy
+102,870
New +$1.47M ﹤0.01% 5059
2014
Q1 		– Sell
-25,981
Closed -$293K – 9660
2013
Q4 		$198K Buy
25,981
+13,377
+106% +$72.1K ﹤0.01% 8284
2013
Q3 		$43K Sell
12,604
-5,276
-30% -$13.9K ﹤0.01% 8255
2013
Q2 		$44K Buy
+17,880
New +$42.9K ﹤0.01% 8000

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's HZNP Position: Q4 2023 in Review

Susquehanna International Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 347,967 shares — an estimated $40.3M sold.

Susquehanna International Group first reported a position in HZNP in Q2 2013 and held it in 37 quarters. The position peaked at $79.8M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Susquehanna International Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 347,967 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.3M.
  • Susquehanna International Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $79.8M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.